Heron Therapeutics Statistics
Total Valuation
HRTX has a market cap or net worth of $165.78 million. The enterprise value is $277.70 million.
Important Dates
The last earnings date was Tuesday, November 12, 2024, before market open.
Earnings Date | Nov 12, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
HRTX has 152.09 million shares outstanding. The number of shares has increased by 16.83% in one year.
Current Share Class | 152.09M |
Shares Outstanding | 152.09M |
Shares Change (YoY) | +16.83% |
Shares Change (QoQ) | +0.34% |
Owned by Insiders (%) | 1.01% |
Owned by Institutions (%) | 57.56% |
Float | 115.00M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 1.24 |
Forward PS | 4.03 |
PB Ratio | n/a |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 2.02 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.28
Current Ratio | 2.28 |
Quick Ratio | 1.61 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -1.75 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -2.31% |
Return on Capital (ROIC) | -3.58% |
Revenue Per Employee | $1.09M |
Profits Per Employee | -$221,960 |
Employee Count | 126 |
Asset Turnover | 0.61 |
Inventory Turnover | 1.65 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +2.75% in the last 52 weeks. The beta is 1.81, so HRTX's price volatility has been higher than the market average.
Beta (5Y) | 1.81 |
52-Week Price Change | +2.75% |
50-Day Moving Average | 1.78 |
200-Day Moving Average | 2.54 |
Relative Strength Index (RSI) | 24.62 |
Average Volume (20 Days) | 2,056,206 |
Short Selling Information
The latest short interest is 28.81 million, so 18.94% of the outstanding shares have been sold short.
Short Interest | 28.81M |
Short Previous Month | 30.64M |
Short % of Shares Out | 18.94% |
Short % of Float | 25.05% |
Short Ratio (days to cover) | 20.19 |
Income Statement
In the last 12 months, HRTX had revenue of $137.74 million and -$27.97 million in losses. Loss per share was -$0.18.
Revenue | 137.74M |
Gross Profit | 65.36M |
Operating Income | -8.32M |
Pretax Income | -48.13M |
Net Income | -27.97M |
EBITDA | -5.70M |
EBIT | -8.32M |
Loss Per Share | -$0.18 |
Full Income Statement Balance Sheet
The company has $70.89 million in cash and $178.25 million in debt, giving a net cash position of -$107.36 million or -$0.71 per share.
Cash & Cash Equivalents | 70.89M |
Total Debt | 178.25M |
Net Cash | -107.36M |
Net Cash Per Share | -$0.71 |
Equity (Book Value) | -40.01M |
Book Value Per Share | -0.26 |
Working Capital | 109.64M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$8.29 million and capital expenditures -$1.32 million, giving a free cash flow of -$9.61 million.
Operating Cash Flow | -8.29M |
Capital Expenditures | -1.32M |
Free Cash Flow | -9.61M |
FCF Per Share | -$0.06 |
Full Cash Flow Statement Margins
Gross margin is 47.45%, with operating and profit margins of -6.04% and -20.30%.
Gross Margin | 47.45% |
Operating Margin | -6.04% |
Pretax Margin | -20.30% |
Profit Margin | -20.30% |
EBITDA Margin | -4.13% |
EBIT Margin | -6.04% |
FCF Margin | -16.51% |
Dividends & Yields
HRTX does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -16.83% |
Shareholder Yield | -16.83% |
Earnings Yield | -16.42% |
FCF Yield | -5.64% |
Analyst Forecast
The average price target for HRTX is $5.67, which is 420.18% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $5.67 |
Price Target Difference | 420.18% |
Analyst Consensus | Strong Buy |
Analyst Count | 3 |
Revenue Growth Forecast (5Y) | 18.78% |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
The last stock split was on January 13, 2014. It was a reverse split with a ratio of 0.05:1.
Last Split Date | Jan 13, 2014 |
Split Type | Reverse |
Split Ratio | 0.05:1 |
Scores
HRTX has an Altman Z-Score of -10.32 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -10.32 |
Piotroski F-Score | 3 |